Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of trimethoprim-sulfametrole in critically ill patients on continuous veno-venous haemofiltration
2014-003403-29Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Sep 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rokitamycin in bacterial disease (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Plasma pharmacokinetics of trimethoprim and sulfametrole. Started Sep 2014; status: completed.
02
Drugs
rokitamycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2014-003403-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003403-29.